Middle East and Africa Blood Screening Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Middle East & Africa blood screening market is expected to reach with healthy CAGR of 8.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
- In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.
- In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.
- In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today’s world. The Blood screening method is found to be more useful for detecting cancer.
- In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.
- Enzo Biochem Inc.
- Meridian Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- BD
- bioMérieux SA
- Beckman Coulter, Inc.
- Abbott
- F. Hoffmann-La Roche Ltd
- Cepheid
- Grifols
- Seimens AG
- Ortho Clinical Diagnostics
- Immucor, Inc.
- Hologic Inc.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 MIDDLE EAST & AFRICA
10.1.1 SOUTH AFRICA
1.1.1 EGYPT
1.1.2 SAUDI ARABIA
1.1.3 UNITED ARAB EMIRATES
1.1.4 ISRAEL
10.1.2 REST OF MIDDLE EAST & AFRICA
11 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST-AND AFRICA
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 MIDDLE EAST & AFRICA
10.1.1 SOUTH AFRICA
1.1.1 EGYPT
1.1.2 SAUDI ARABIA
1.1.3 UNITED ARAB EMIRATES
1.1.4 ISRAEL
10.1.2 REST OF MIDDLE EAST & AFRICA
11 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST-AND AFRICA
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
LIST OF TABLES
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 MIDDLE EAST-AND AFRICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 MIDDLE EAST-AND AFRICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 MIDDLE EAST-AND AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 MIDDLE EAST-AND AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 MIDDLE EAST-AND AFRICA SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 MIDDLE EAST-AND AFRICA RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 MIDDLE EAST-AND AFRICA NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 MIDDLE EAST-AND AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 MIDDLE EAST-AND AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 MIDDLE EAST-AND AFRICA WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 MIDDLE EAST-AND AFRICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 MIDDLE EAST-AND AFRICA ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 MIDDLE EAST-AND AFRICA DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 MIDDLE EAST-AND AFRICA COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 MIDDLE EAST-AND AFRICA CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 MIDDLE EAST-AND AFRICA INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 MIDDLE EAST-AND AFRICA RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 MIDDLE EAST-AND AFRICA HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 MIDDLE EAST-AND AFRICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 MIDDLE EAST-AND AFRICA DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 MIDDLE EAST-AND AFRICA BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 MIDDLE EAST-AND AFRICA HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 MIDDLE EAST-AND AFRICA CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 MIDDLE EAST-AND AFRICA AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
Table 37 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 MIDDLE EAST & AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 MIDDLE EAST & AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 48 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 SOUTH AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 SOUTH AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 SOUTH AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 SOUTH AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 SOUTH AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 60 SOUTH AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 REST OF MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 MIDDLE EAST-AND AFRICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 MIDDLE EAST-AND AFRICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 MIDDLE EAST-AND AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 MIDDLE EAST-AND AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 MIDDLE EAST-AND AFRICA SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 MIDDLE EAST-AND AFRICA RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 MIDDLE EAST-AND AFRICA NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 MIDDLE EAST-AND AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 MIDDLE EAST-AND AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 MIDDLE EAST-AND AFRICA WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 MIDDLE EAST-AND AFRICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 MIDDLE EAST-AND AFRICA ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 MIDDLE EAST-AND AFRICA DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 MIDDLE EAST-AND AFRICA COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 MIDDLE EAST-AND AFRICA CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 MIDDLE EAST-AND AFRICA INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 MIDDLE EAST-AND AFRICA RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 MIDDLE EAST-AND AFRICA HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 MIDDLE EAST-AND AFRICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 MIDDLE EAST-AND AFRICA DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 MIDDLE EAST-AND AFRICA BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 MIDDLE EAST-AND AFRICA HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 MIDDLE EAST-AND AFRICA CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 MIDDLE EAST-AND AFRICA AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
Table 37 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 MIDDLE EAST & AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 MIDDLE EAST & AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 48 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 SOUTH AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 SOUTH AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 SOUTH AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 SOUTH AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 SOUTH AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 60 SOUTH AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 REST OF MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
LIST OF FIGURES
Figure 1 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET
Figure 12 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 15 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 16 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 17 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 18 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY END USER, 2017
Figure 19 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 20 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 21 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 22 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025)
Figure 23 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 24 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 1 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET
Figure 12 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 15 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 16 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 17 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 18 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY END USER, 2017
Figure 19 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 20 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 21 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 22 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025)
Figure 23 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 24 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
